Metformin and pioglitazone are widely used to treat insulin resistance and to regulate steroidogenic enzymes such as HSD3B2 and CYP17A1 [22,23,24,25,26,27]; therefore, they were used here as positive controls in our PCOS-like model. Here, CYP17A1 is linked to polycystic ovary syndrome.